SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions

SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions

Tom Loney, Thomas E. Adrian, Alawi Alsheikh-Ali, Afaf Kamal-Eldin, Norbert Nowotny, Abiola C. Senok, Tahir A. Rizvi, Farah Mustafa, Cesare STEFANINI, Mohammed Uddin, Ahmed H. Hassan Al Marzouqi, Hanan Al Suwaidi, Nabeel Alsabeeha

The COVID-19 pandemic is due to infection caused by the novel SARS-CoV-2 virus that impacts the lower respiratory tract. The spectrum of symptoms ranges from asymptomatic infections to mild respiratory symptoms to the lethal form of COVID-19 which is associated with severe pneumonia, acute respiratory distress, and fatality. To address this global crisis, up-to-date information on viral genomics and transcriptomics is crucial for understanding the origins and global dispersion of the virus, providing insights into viral pathogenicity, transmission, and epidemiology, and enabling strategies for therapeutic interventions, drug discovery, and vaccine development. Therefore, this review provides a comprehensive overview of COVID-19 epidemiology, genomic etiology, findings from recent transcriptomic map analysis, viral-human protein interactions, molecular diagnostics, and the current status of vaccine and novel therapeutic intervention development. Moreover, we provide an extensive list of resources that will help the scientific community access numerous types of databases related to SARS-CoV-2 OMICs and approaches to therapeutics related to COVID-19 treatment.

2020

coronavirus, viral genomics, Pandemic, SARS-CoV-2, COVID-19

DOI: 10.3390/v12050526

Viruses

MDPI AG

Microbiology